{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:06:20Z","timestamp":1790262380497,"version":"4.1.0"},"reference-count":58,"publisher":"Society of Nuclear Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2026,8,19]]},"DOI":"10.2967\/jnumed.126.272814","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:30:18Z","timestamp":1790260218000},"page":"jnumed.126.272814","source":"Crossref","is-referenced-by-count":0,"title":["Glypican-3 as a Theranostic Target in Hepatocellular Carcinoma"],"prefix":"10.2967","author":[{"given":"Wolfgang A.","family":"Weber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Eiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantin","family":"Lapa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Ehmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"key":"2026092407301020000_jnumed.126.272814v1.1","unstructured":"Liver cancer. Cancer Today website. https:\/\/gco.iarc.who.int\/today\/en\/fact-sheets-cancers\/11\/liver-and-intrahepatic-bile-ducts. Accessed August 25, 2026."},{"key":"2026092407301020000_jnumed.126.272814v1.2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.70043"},{"key":"2026092407301020000_jnumed.126.272814v1.3","doi-asserted-by":"crossref","first-page":"e222801","DOI":"10.1148\/radiol.222801","article-title":"LI-RADS: looking back, looking forward","volume":"307","author":"Chernyak","year":"2023","journal-title":"Radiology."},{"key":"2026092407301020000_jnumed.126.272814v1.4","doi-asserted-by":"crossref","first-page":"e231501","DOI":"10.1148\/radiol.231501","article-title":"LI-RADS CT and MRI ancillary feature association with hepatocellular carcinoma and malignancy: an individual participant data meta-analysis","volume":"310","author":"Dawit","year":"2024","journal-title":"Radiology."},{"key":"2026092407301020000_jnumed.126.272814v1.5","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/HEP.0000000000001269","article-title":"Critical update: AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma","volume":"82","author":"Taddei","year":"2025","journal-title":"Hepatology."},{"key":"2026092407301020000_jnumed.126.272814v1.6","doi-asserted-by":"crossref","first-page":"e220646","DOI":"10.1148\/radiol.220646","article-title":"Percentages of hepatocellular carcinoma in LI-RADS categories with CT and MRI: a systematic review and meta-analysis","volume":"307","author":"Lee","year":"2023","journal-title":"Radiology."},{"key":"2026092407301020000_jnumed.126.272814v1.7","doi-asserted-by":"crossref","first-page":"e222855","DOI":"10.1148\/radiol.222855","article-title":"A multicenter assessment of interreader reliability of LI-RADS version 2018 for MRI and CT","volume":"307","author":"Hong","year":"2023","journal-title":"Radiology."},{"key":"2026092407301020000_jnumed.126.272814v1.8","doi-asserted-by":"crossref","first-page":"7622","DOI":"10.1007\/s00330-024-10846-w","article-title":"Diagnostic performance of CT\/MRI LI-RADS v2018 in non-cirrhotic steatotic liver disease","volume":"34","author":"Cao","year":"2024","journal-title":"Eur Radiol."},{"key":"2026092407301020000_jnumed.126.272814v1.9","doi-asserted-by":"crossref","first-page":"100364","DOI":"10.1016\/j.jhepr.2021.100364","article-title":"Non-invasive imaging criteria for the diagnosis of hepatocellular carcinoma in non-cirrhotic patients with chronic hepatitis B","volume":"3","author":"Moctezuma-Vel\u00e1zquez","year":"2021","journal-title":"JHEP Rep."},{"key":"2026092407301020000_jnumed.126.272814v1.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2025.10.020"},{"key":"2026092407301020000_jnumed.126.272814v1.11","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.02745"},{"key":"2026092407301020000_jnumed.126.272814v1.12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1915745"},{"key":"2026092407301020000_jnumed.126.272814v1.13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(25)00403-9"},{"key":"2026092407301020000_jnumed.126.272814v1.14","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S2468-1253(22)00091-7","article-title":"Radiation segmentectomy for curative intent of unresectable very early to early stage hepatocellular carcinoma (RASER): a single-centre, single-arm study","volume":"7","author":"Kim","year":"2022","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"2026092407301020000_jnumed.126.272814v1.15","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1002\/cncr.24884","article-title":"Therapeutic equivalence in survival for hepatic arterial chemoembolization and yttrium 90 microsphere treatments in unresectable hepatocellular carcinoma","volume":"116","author":"Carr","year":"2010","journal-title":"Cancer."},{"key":"2026092407301020000_jnumed.126.272814v1.16","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.10.049"},{"key":"2026092407301020000_jnumed.126.272814v1.17","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.jvir.2022.11.036","article-title":"Radioembolization for intermediate-stage hepatocellular carcinoma maintains liver function and permits systemic therapy at progression","volume":"34","author":"Ranganathan","year":"2023","journal-title":"J Vasc Interv Radiol."},{"key":"2026092407301020000_jnumed.126.272814v1.18","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30683-6"},{"key":"2026092407301020000_jnumed.126.272814v1.19","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.76.0892"},{"key":"2026092407301020000_jnumed.126.272814v1.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.08.006"},{"key":"2026092407301020000_jnumed.126.272814v1.21","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S2468-1253(21)00305-8","article-title":"Radioembolisation with Y90-resin microspheres followed by nivolumab for advanced hepatocellular carcinoma (CA 209-678): a single arm, single centre, phase 2 trial","volume":"6","author":"Tai","year":"2021","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"2026092407301020000_jnumed.126.272814v1.22","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.3390\/cancers17172745","article-title":"Contemporary clinical utilization of radioembolization with immune checkpoint inhibitors as first-line treatment in HCC: real-world report on safety and outcomes","volume":"17","author":"N\u00fa\u00f1ez","year":"2025","journal-title":"Cancers (Basel)."},{"key":"2026092407301020000_jnumed.126.272814v1.23","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.108.055087"},{"key":"2026092407301020000_jnumed.126.272814v1.24","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-biochem-060713-035314"},{"key":"2026092407301020000_jnumed.126.272814v1.25","doi-asserted-by":"crossref","first-page":"C694","DOI":"10.1152\/ajpcell.00045.2022","article-title":"The function of glypicans in the mammalian embryo","volume":"322","author":"Filmus","year":"2022","journal-title":"Am J Physiol Cell Physiol."},{"key":"2026092407301020000_jnumed.126.272814v1.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2006.05.016"},{"key":"2026092407301020000_jnumed.126.272814v1.27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2010.03553.x"},{"key":"2026092407301020000_jnumed.126.272814v1.28","doi-asserted-by":"publisher","DOI":"10.1097\/PAP.0b013e3181992455"},{"key":"2026092407301020000_jnumed.126.272814v1.29","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-014-1669-4"},{"key":"2026092407301020000_jnumed.126.272814v1.30","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e318219ac78"},{"key":"2026092407301020000_jnumed.126.272814v1.31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2009.01206.x"},{"key":"2026092407301020000_jnumed.126.272814v1.32","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-08261-8"},{"key":"2026092407301020000_jnumed.126.272814v1.33","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.824208"},{"key":"2026092407301020000_jnumed.126.272814v1.34","first-page":"665","article-title":"Targeting glypican-3 for liver cancer therapy: clinical applications and detection methods","volume":"13","author":"Zhang","year":"2025","journal-title":"J Clin Transl Hepatol."},{"key":"2026092407301020000_jnumed.126.272814v1.35","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13550-018-0374-8","article-title":"I-124 codrituzumab imaging and biodistribution in patients with hepatocellular carcinoma","volume":"8","author":"Carrasquillo","year":"2018","journal-title":"EJNMMI Res."},{"key":"2026092407301020000_jnumed.126.272814v1.36","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.113.132118"},{"key":"2026092407301020000_jnumed.126.272814v1.37","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.114.145102"},{"key":"2026092407301020000_jnumed.126.272814v1.38","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1158\/1078-0432.CCR-25-1856","article-title":"Glypican-3-targeted PET imaging for precise diagnosis of hepatocellular carcinoma: from bench to bedside","volume":"32","author":"Lin","year":"2026","journal-title":"Clin Cancer Res."},{"key":"2026092407301020000_jnumed.126.272814v1.39","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1007\/s00259-025-07739-5","article-title":"Glypican-3-targeted immunoPET imaging of hepatocellular carcinoma: a translational study","volume":"53","author":"Lin","year":"2026","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026092407301020000_jnumed.126.272814v1.40","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1007\/s00259-022-05723-x","article-title":"GPC3-targeted immunoPET imaging of hepatocellular carcinomas","volume":"49","author":"An","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026092407301020000_jnumed.126.272814v1.41","doi-asserted-by":"crossref","first-page":"5237","DOI":"10.1158\/1078-0432.CCR-25-2587","article-title":"Diagnosis and treatment response monitoring of liver cancer using glypican-3-targeted single domain antibody positron emission tomography","volume":"31","author":"Fayn","year":"2025","journal-title":"Clin Cancer Res."},{"key":"2026092407301020000_jnumed.126.272814v1.42","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btw197"},{"key":"2026092407301020000_jnumed.126.272814v1.43","doi-asserted-by":"publisher","DOI":"10.1021\/acs.bioconjchem.6b00030"},{"key":"2026092407301020000_jnumed.126.272814v1.44","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00726-017-2517-z","article-title":"Imaging the expression of glypican-3 in hepatocellular carcinoma by PET","volume":"50","author":"Wang","year":"2018","journal-title":"Amino Acids."},{"key":"2026092407301020000_jnumed.126.272814v1.45","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.123.266766"},{"key":"2026092407301020000_jnumed.126.272814v1.46","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.124.268147"},{"key":"2026092407301020000_jnumed.126.272814v1.47","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.124.269290"},{"key":"2026092407301020000_jnumed.126.272814v1.48","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.125.270267"},{"key":"2026092407301020000_jnumed.126.272814v1.49","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.262562"},{"key":"2026092407301020000_jnumed.126.272814v1.50","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.125.270814"},{"key":"2026092407301020000_jnumed.126.272814v1.51","unstructured":"Study of the theranostic pair RYZ811 (diagnostic) and RYZ801 (therapeutic) to identify and treat subjects with GPC3+ (glypican-3) unresectable HCC (GPC3) (NCT06726161). ClinicalTrials.gov website. https:\/\/clinicaltrials.gov\/study\/NCT06726161. Accessed August 25, 2026."},{"key":"2026092407301020000_jnumed.126.272814v1.52","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/hepr.12320","article-title":"Expression and clinical implications of HAb18G\/CD147 in hepatocellular carcinoma","volume":"45","author":"Zhu","year":"2015","journal-title":"Hepatol Res."},{"key":"2026092407301020000_jnumed.126.272814v1.53","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S2468-1253(19)30422-4","article-title":"Adjuvant 131I-metuximab for hepatocellular carcinoma after liver resection: a randomised, controlled, multicentre, open-label, phase 2 trial","volume":"5","author":"Li","year":"2020","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"2026092407301020000_jnumed.126.272814v1.54","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.125.271565"},{"key":"2026092407301020000_jnumed.126.272814v1.55","doi-asserted-by":"crossref","first-page":"e22550","DOI":"10.1002\/advs.202522550","article-title":"The development and pilot clinical study of CD147 targeted antagonistic peptide probe for tumor imaging","volume":"13","author":"Ma","year":"2026","journal-title":"Adv Sci (Weinh)."},{"key":"2026092407301020000_jnumed.126.272814v1.56","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-0151"},{"key":"2026092407301020000_jnumed.126.272814v1.57","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.125.270167"},{"key":"2026092407301020000_jnumed.126.272814v1.58","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.125.270755"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.126.272814","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:30:22Z","timestamp":1790260222000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.126.272814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":58,"alternative-id":["10.2967\/jnumed.126.272814"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.126.272814","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]}}}